Orzaks Ilac Ve Kimyanayi Ticaret AS (IST:ORZAX) NonCurrent Deferred Revenue: ₺0 Mil (As of Dec. 2025)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

IST:ORZAX Orzaks Ilac Ve Kimya Sanayi Ticaret AS IST:ORZAX
18 GF Score
Price ₺87.50
! 3 Warning Signs
View Full Analysis

What is Orzaks Ilac Ve Kimyanayi Ticaret AS NonCurrent Deferred Revenue?

Orzaks Ilac Ve Kimyanayi Ticaret AS IST:ORZAX -1.41% 18 NonCurrent Deferred Revenue is ₺0 Mil as of Dec. 2025. GuruFocus rates IST:ORZAX with a GF Score™ of 18/100. The stock has 3 warning signs investors should review.

Non-Current Deferred Revenue represents the non-current portion of deferred revenue amount as of the balance sheet date. Deferred revenue is a liability related to revenue producing activity for which revenue has not yet been recognized and is not expected be recognized in the next twelve months.

Orzaks Ilac Ve Kimyanayi Ticaret AS's non-current deferred revenue for the quarter that ended in Dec. 2025 was ₺0 Mil.

Orzaks Ilac Ve Kimyanayi Ticaret AS NonCurrent Deferred Revenue Related Terms

Orzaks Ilac Ve Kimyanayi Ticaret AS NonCurrent Deferred Revenue Historical Data

* Premium members only.

The historical data trend for Orzaks Ilac Ve Kimyanayi Ticaret AS's NonCurrent Deferred Revenue can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Orzaks Ilac Ve Kimyanayi Ticaret AS NonCurrent Deferred Revenue Chart

Orzaks Ilac Ve Kimyanayi Ticaret AS Annual Data
Trend Dec23 Dec24 Dec25
NonCurrent Deferred Revenue
0.00 0.00 0.00

Orzaks Ilac Ve Kimyanayi Ticaret AS Semi-Annual Data
Dec23 Dec24 Dec25
NonCurrent Deferred Revenue 0.00 0.00 0.00
IST:ORZAX
18GF Score
Orzaks Ilac Ve Kimya Sanayi Ticaret AS IST:ORZAX
NonCurrent Deferred Revenue is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis
What does a NonCurrent Deferred Revenue of ₺0 Mil mean?
Orzaks Ilac Ve Kimyanayi Ticaret AS (IST:ORZAX) has a NonCurrent Deferred Revenue of ₺0 Mil as of Dec. 2025. Deferred revenue is a liability related to revenue producing activity for which revenue has not yet been recognized and is not expected be recognized in the next twelve months. View historical data on Orzaks Ilac Ve Kimyanayi Ticaret AS and its competitors.
Is Orzaks Ilac Ve Kimyanayi Ticaret AS's NonCurrent Deferred Revenue too high?
Orzaks Ilac Ve Kimyanayi Ticaret AS's current NonCurrent Deferred Revenue is ₺0 Mil. Overall, Orzaks Ilac Ve Kimyanayi Ticaret AS has a GF Score™ of 18/100, reflecting its overall financial health beyond just this single metric.
How does Orzaks Ilac Ve Kimyanayi Ticaret AS's NonCurrent Deferred Revenue compare to KHC and GIS?
Orzaks Ilac Ve Kimyanayi Ticaret AS's NonCurrent Deferred Revenue of ₺0 Mil can be compared against companies in the Consumer Packaged Goods industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good NonCurrent Deferred Revenue for a Consumer Packaged Goods company?
A good NonCurrent Deferred Revenue depends on the Consumer Packaged Goods industry context. However, NonCurrent Deferred Revenue should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high NonCurrent Deferred Revenue mean?
A high NonCurrent Deferred Revenue can signal that a stock is expensive relative to its fundamentals. Deferred revenue is a liability related to revenue producing activity for which revenue has not yet been recognized and is not expected be recognized in the next twelve months. View historical data on Orzaks Ilac Ve Kimyanayi Ticaret AS and its competitors. Orzaks Ilac Ve Kimyanayi Ticaret AS's current NonCurrent Deferred Revenue is ₺0 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Orzaks Ilac Ve Kimyanayi Ticaret AS stock overvalued right now?
Orzaks Ilac Ve Kimyanayi Ticaret AS (IST:ORZAX) has a current NonCurrent Deferred Revenue of ₺0 Mil. The current NonCurrent Deferred Revenue is ₺0 Mil. Orzaks Ilac Ve Kimyanayi Ticaret AS's overall GF Score™ is 18/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is NonCurrent Deferred Revenue calculated?
NonCurrent Deferred Revenue is calculated from a company's financial statements. For Orzaks Ilac Ve Kimyanayi Ticaret AS (IST:ORZAX), the current NonCurrent Deferred Revenue is ₺0 Mil as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Orzaks Ilac Ve Kimyanayi Ticaret AS Business Description

Address Esentepe Mah, Buyukdere Cad, No:171, Metrocity Is Merkezi A Blok Kat:1, Sisli, Istanbul, TUR
Orzaks Ilac Ve Kimya Sanayi Ticaret AS operates as a sports nutrition brand. Its products are Vitamin Series, Vitamin D Series, Mineral Series, Magnesium Series, Omega 3 Series, Plant Extracts, Immune Series, Probiotic Series, Bone And Joint Series, and Others. The group offers its products under various brands such as Ocean, Day2Day, Imunol, Cosakondrin, Efervit, Bigflor, and Strains.
18GF Score

Get the complete analysis for IST:ORZAX

NonCurrent Deferred Revenue is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

₺87.50
Price